Notice of Intent to Sole Source-Roche Chemistry Analyzer-Supplies-Service-Taos Picuris Service Unit
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Indian Health Service, Albuquerque Area Office, intends to award a sole source commercial item contract to Roche Diagnostics Corporation for the uninterrupted operation of clinical chemistry services at the Taos Picuris Health Center. The procurement encompasses the complete Roche COBAS Pure chemistry analyzer system, including proprietary reagents, calibrators, controls, consumables, manufacturer-maintained service, replacement parts, 24-hour technical support, software integration with RPMS, firmware updates, and compliance with all regulatory and safety requirements. Roche is the only authorized provider of these items under the VA Federal Supply Schedule V797P 7347A, and no other vendor has legal authority to manufacture, service, or support the proprietary technology, including the analyzer architecture, reagent formulations, firmware, and interface protocols. The requirement is justified under FAR 6.302-1 due to the exclusive intellectual property rights held by Roche and the absence of any alternative sources capable of maintaining existing clinical workflows. The contract will be a firm fixed price commercial item agreement under FAR Part 12, with a base year running from January 1, 2027, through December 31, 2027, and four optional one-year extensions through December 31, 2031. No competitive solicitation will be issued; this notice serves only as an announcement of intent to proceed with Roche as the sole source. Interested parties may submit a capability statement only if they can prove legal authorization to sell Roche-branded items, hold active access to the VA FSS contract, provide certified manufacturer support, and demonstrate full compatibility with existing Roche-configured systems. Proposals for alternative analyzers, third-party reagents, or non-Roche platforms will be rejected. Responses must be submitted by August 14, 2026, at 4:00 PM Mountain Time to the designated contract specialist, and if no valid submissions are received, the contract will be awarded directly to Roche Diagnostics Corporation.
General Info
Agency
NAICS
Place of Performance
Taos, NM, 87571, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
NOTICE OF INTENT TO SOLE SOURCE
Agency: Indian Health Service (IHS), Albuquerque Area Office
PSC: DA10
NAICS: 334516 – Analytical Laboratory Instrument Manufacturing
Notice Type: Special Notice – Intent to Sole Source
Authority: FAR 6.302 1 – Only One Responsible Source
Set Aside: Not Applicable
1. Description of Requirement
The Indian Health Service (IHS), Albuquerque Area Office, Taos Picuris Health Center intends to issue a sole source commercial item procurement under FAR Part 12 to Roche Diagnostics Corporation for brand name only Roche COBAS Pure chemistry analyzer equipment, proprietary reagents, calibrators, controls, consumables, manufacturer maintenance, replacement parts, and technical/software support required for uninterrupted clinical chemistry operations.
All Roche chemistry products and services are proprietary and must be acquired exclusively through Roche’s VA Federal Supply Schedule (FSS) Contract V797P 7347A, which is the only authorized federal contract vehicle for these items.
Vendor: Roche Diagnostics Corporation
UEI: JDMDFEZBYH36
Address: 9115 Hague Rd, P.O. Box 50457, Indianapolis, IN 46250 0457
Required brand name Roche items include, but are not limited to:
• Roche COBAS Pure chemistry analyzer package
• Clinical chemistry reagents, calibrators, QC materials, and assay cartridges
• Required consumables and analyzer maintenance supplies
• Refrigerated / frozen reagent shipping according to Roche specifications
• Manufacturer preventive maintenance and field service support
• 24 hour technical support and analyzer replacement if required
• RPMS compatible connectivity, software integration, and firmware updates
• All manufacturer approved QA, safety, and regulatory compliance items
2. Justification for Sole Source
Market research confirms that Roche Diagnostics is the only responsible source authorized to provide Roche COBAS Pure analyzers, proprietary chemistry reagents, firmware, technical support, and maintenance. Roche retains all intellectual property rights associated with:
• COBAS Pure chemistry analyzer architecture
• Reagent formulations
• Analyzer firmware and calibration files
• Software connectivity and interface modules
• RPMS integration protocols
• Maintenance parts and service procedures
Roche further confirmed that only VA FSS Contract V797P 7347A is authorized for federal procurement of COBAS Pure chemistry systems and associated consumables.
No other vendor can legally manufacture, sell, service, or integrate Roche chemistry products, nor do any other vendors possess proprietary access or the ability to support existing workflows at Taos Picuris Health Center.
Therefore, a sole source procurement is justified under FAR 6.302 1 – Only One Responsible Source.
3. This Notice Is Not a Request for Quotes
This Special Notice solely announces the Government’s intent to negotiate on a sole source basis with Roche Diagnostics Corporation.
No competitive solicitation will be issued.
4. Capability Statement Instructions
Interested parties may submit a capability statement ONLY if they can demonstrate:
• Legal authority to sell Roche brand name chemistry equipment and proprietary reagents
• Authorization under VA FSS Contract V797P 7347A specifically
• Certification to provide manufacturer authorized maintenance and technical support
• Proven compatibility with existing Roche configured RPMS chemistry workflows
• Ability to comply with all Roche shipping, storage, safety, and regulatory requirements
Capability statements proposing alternative analyzers, third party reagents, substitute chemistry systems, or non Roche platforms will NOT be considered.
5. Response Deadline
Responses must be submitted by:
August 14, 2026 – 4:00 PM Mountain Time
Send responses to:
Raelynn Ray, Contract Specialist
Indian Health Service – Albuquerque Area Office
Email: raelynn.ray@ihs.gov
Phone: 505 256 6757
6. Intended Award
If no valid capability statements are received, the Government will award a sole source, firm fixed price, commercial item contract to Roche Diagnostics Corporation under FAR 6.302 1, using Roche’s VA FSS Contract V797P 7347A.
7. Period of Performance
Base Year + Four (4) Option Years:
• Base Year: 01/01/2027 – 12/31/2027
• Option Year 1: 01/01/2028 – 12/31/2028
• Option Year 2: 01/01/2029 – 12/31/2029
• Option Year 3: 01/01/2030 – 12/31/2030
• Option Year 4: 01/01/2031 – 12/31/2031
8. Contract Type
Firm fixed price commercial item contract under FAR Part 12
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → Albuquerque Area Indian Health Svc
Same awarding agency
